Cardiovascular involvement in systemic lupus erythematosus: an autopsy study of 27 patients in India

J Postgrad Med. 2006 Jan-Mar;52(1):5-10; discussion 10.

Abstract

Background: Although cardiovascular disease (CVD) is recognized as a leading cause of death in patients with systemic lupus erythematosus (SLE) in western countries, there is hardly any data regarding Indian subjects with SLE.

Aims: To determine the incidence of cardiac abnormalities and vascular lesions at autopsy and to assess their contribution to the mortality in patients with SLE.

Settings and design: Retrospective retrieval of reports of autopsies performed on 35 patients with SLE over a 11 year period and analysis of 27 cases with cardiac and/or vascular lesions.

Materials and methods: Gross and microscopic features in 27 autopsies were analyzed with special attention to the heart and the vasculature of all organs. Findings were correlated with clinical features and ante-mortem investigations. Their contribution towards mortality was assessed.

Results: Valvar lesions were the commonest cardiac lesions noted with non-bacterial thrombotic endocarditis in nine (33.33%), valvar thickening in two (7.41%), Libman-Sacks endocarditis and infective endocarditis in one (3.70%) each. Myocarditis and myocardial scarring were seen in 10 (37.03%) and seven (25.92%) cases, respectively. Fibrinous pericarditis was noted in seven (25.92%). Thromboses/embolism, vasculitis and severe coronary atherosclerosis were seen in nine (33.33%), five (18.52%) and one (3.70%) subjects, respectively. Renal disease [13, 48.14%] and cardiovascular manifestations [8, 29.62%] were the leading causes of death in our patient population.

Conclusion: CVD contributes significantly to the mortality in patients with SLE in India. It is second only to renal disease in this regard.

MeSH terms

  • Adolescent
  • Adult
  • Autopsy
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / pathology*
  • Child
  • Female
  • Humans
  • Incidence
  • India / epidemiology
  • Lupus Erythematosus, Systemic / mortality
  • Lupus Erythematosus, Systemic / pathology*
  • Male
  • Retrospective Studies